Clinical Trial Update: Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating stereotactic radiation combined with immunotherapy in advanced triple negative breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED